Effects of Pregnenolone on Perceived Social Isolation
- Conditions
- Perceived Social Isolation
- Interventions
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 34
- Registration Number
- NCT02826577
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Thirty Million Words- Well Baby Initiative
- Conditions
- BehaviorCommunicationLanguage
- Interventions
- Behavioral: Thirty Million Words- Well BabyOther: Safety Starts at Home
- First Posted Date
- 2016-06-23
- Last Posted Date
- 2020-03-24
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 952
- Registration Number
- NCT02812017
- Locations
- 🇺🇸
Lawndale Christian Health Center - Archer Avenue, Chicago, Illinois, United States
🇺🇸Advocate Medical Group, Chicago, Illinois, United States
🇺🇸Lawndale Christian Health Center, Chicago, Illinois, United States
Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2016-06-02
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 29
- Registration Number
- NCT02788981
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸Northshore University HealthSystem, Evanston, Illinois, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study
- Conditions
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Interventions
- Drug: FOLFIRINOX (oxaliplatin, leucovorin, irinotecan)
- First Posted Date
- 2016-05-25
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 1
- Registration Number
- NCT02782182
- Locations
- 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months
- Conditions
- Blood Coagulation Disorders
- Interventions
- Biological: Plasma
- First Posted Date
- 2016-05-17
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT02774317
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Effects of Flibanserin on the Pre- and Post-menopausal Female Brain
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 57
- Registration Number
- NCT02770768
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 40
- Registration Number
- NCT02754518
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Partner Services Pre-exposure Prophylaxis (PS-PrEP)
- Conditions
- HIV Transmission, Transtheoretical Model of Change
- Interventions
- Behavioral: PS-PrEP Intervention GroupBehavioral: PrEPLine Control Group
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 164
- Registration Number
- NCT02749955
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- Conditions
- Brain Metastases
- Interventions
- Procedure: Stereotactic Radiosurgery
- First Posted Date
- 2016-04-21
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 166
- Registration Number
- NCT02747303
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain
- Conditions
- Autosomal Dominant Polycystic Kidney Disease
- Interventions
- Device: Vessix
- First Posted Date
- 2016-04-21
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT02746419